Akli S, Keyomarsi K: Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy. Cancer Biol Ther. 2003, Suppl 1: S38-S47.
Google Scholar
Cassia R, Moreno-Bueno G, Rodriguez-Perales S, Hardisson D, Cigudosa JC, Palacios J: Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol. 2003, 201: 589-595. 10.1002/path.1474.
Article
CAS
PubMed
Google Scholar
Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, et al: Cyclin E overexpression and amplification in human tumours. J Pathol. 2003, 200: 375-382. 10.1002/path.1356.
Article
CAS
PubMed
Google Scholar
Bloom J, Pagano M: Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol. 2003, 13: 41-47. 10.1016/S1044-579X(02)00098-6.
Article
CAS
PubMed
Google Scholar
Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ: Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 2001, 294: 173-177. 10.1126/science.1065203.
Article
CAS
PubMed
Google Scholar
Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C: Inactivation of hCDC4 can cause chromosomal instability. Nature. 2004, 428: 77-81. 10.1038/nature02313.
Article
CAS
PubMed
Google Scholar
Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI: Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 2001, 413: 316-322. 10.1038/35095076.
Article
CAS
PubMed
Google Scholar
Spruck CH, Strohmaier H, Sangfelt O, Muller HM, Hubalek M, Muller-Holzner E, Marth C, Widschwendter M, Reed SI: hCDC4 gene mutations in endometrial cancer. Cancer Res. 2002, 62: 4535-4539.
CAS
PubMed
Google Scholar
Bortner DM, Rosenberg MP: Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol. 1997, 17: 453-459.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harwell RM, Porter DC, Danes C, Keyomarsi K: Processing of cyclin E differs between normal and tumor breast cells. Cancer Res. 2000, 60: 481-489.
CAS
PubMed
Google Scholar
Porter DC, Zhang N, Danes C, McGahren MJ, Harwell RM, Faruki S, Keyomarsi K: Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol. 2001, 21: 6254-6269. 10.1128/MCB.21.18.6254-6269.2001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995, 15: 2612-2624.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wingate H, Bedrosian I, Akli S, Keyomarsi K: The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells. Cell Cycle. 2003, 2: 461-466.
Article
CAS
PubMed
Google Scholar
Bedrosian I, Lu KH, Verschraegen C, Keyomarsi K: Cyclin E deregulation alters the biologic properties of ovarian cancer cells. Oncogene. 2004, 23: 2648-2657. 10.1038/sj.onc.1207408.
Article
CAS
PubMed
Google Scholar
Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, et al: Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002, 347: 1566-1575. 10.1056/NEJMoa021153.
Article
CAS
PubMed
Google Scholar
Akli S, Zheng P-J, Multani AS, Wingate HF, Pathak S, Zhang N, Tucker SL, Chang S, Keyomarsi K: Tumor-specific low-molecular-weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res. 2004,
Google Scholar
Ohtsubo M, Roberts JM: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science. 1993, 259: 1908-1912.
Article
CAS
PubMed
Google Scholar
Sgambato A, Doki Y, Schieren I, Weinstein IB: Effects of cyclin E overexpression on cell growth and response to transforming growth factor beta depend on cell context and p27Kip1 expression. Cell Growth Differ. 1997, 8: 393-405.
CAS
PubMed
Google Scholar
Ghosh PM, Moyer ML, Mott GE, Kreisberg JI: Effect of cyclin E overexpression on lovastatin-induced G1 arrest and RhoA inactivation in NIH3T3 cells. J Cell Biochem. 1999, 74: 532-543. 10.1002/(SICI)1097-4644(19990915)74:4<532::AID-JCB3>3.3.CO;2-5.
Article
CAS
PubMed
Google Scholar
Dhillon NK, Mudryj M: Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene. 2002, 21: 4626-4634. 10.1038/sj.onc.1205576.
Article
CAS
PubMed
Google Scholar
Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL: Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells. Cancer Res. 2002, 62: 6916-6923.
CAS
PubMed
Google Scholar
Span PN, Tjan-Heijnen VC, Manders P, Beex LV, Sweep CG: Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Oncogene. 2003, 22: 4898-4904. 10.1038/sj.onc.1206818.
Article
CAS
PubMed
Google Scholar
Spruck CH, Won KA, Reed SI: Deregulated cyclin E induces chromosome instability. Nature. 1999, 401: 297-300. 10.1038/45836.
Article
CAS
PubMed
Google Scholar
Sutter T, Dansranjavin T, Lubinski J, Debniak T, Giannakudis J, Hoang-Vu C, Dralle H: Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma. Int J Colorectal Dis. 2002, 17: 374-380. 10.1007/s00384-002-0390-y.
Article
PubMed
Google Scholar
Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P: Cyclin E ablation in the mouse. Cell. 2003, 114: 431-443. 10.1016/S0092-8674(03)00645-7.
Article
CAS
PubMed
Google Scholar
Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M: Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet. 2003, 35: 25-31. 10.1038/ng1232.
Article
CAS
PubMed
Google Scholar
Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P: Cdk2 knockout mice are viable. Curr Biol. 2003, 13: 1775-1785. 10.1016/j.cub.2003.09.024.
Article
CAS
PubMed
Google Scholar
Geisen C, Moroy T: The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein. J Biol Chem. 2002, 277: 39909-39918. 10.1074/jbc.M205919200.
Article
CAS
PubMed
Google Scholar